Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Masupirdine by Suven Life Sciences for Dementia Associated With Alzheimer's Disease: Likelihood of Approval
Masupirdine is under clinical development by Suven Life Sciences and currently in Phase III for Dementia Associated With Alzheimer's Disease....
Samelisant by Suven Life Sciences for Narcolepsy: Likelihood of Approval
Samelisant is under clinical development by Suven Life Sciences and currently in Phase II for Narcolepsy. According to GlobalData, Phase...
Usmarapride by Suven Life Sciences for Cognitive Disorders: Likelihood of Approval
Usmarapride is under clinical development by Suven Life Sciences and currently in Phase I for Cognitive Disorders. According to GlobalData,...
Usmarapride by Suven Life Sciences for Alzheimer's Disease: Likelihood of Approval
Usmarapride is under clinical development by Suven Life Sciences and currently in Phase I for Alzheimer's Disease. According to GlobalData,...
Ropanicant by Suven Life Sciences for Major Depressive Disorder: Likelihood of Approval
Ropanicant is under clinical development by Suven Life Sciences and currently in Phase I for Major Depressive Disorder. According to...
Samelisant by Suven Life Sciences for Narcolepsy: Likelihood of Approval
Samelisant is under clinical development by Suven Life Sciences and currently in Phase II for Narcolepsy. According to GlobalData, Phase...